Engineering human knock-in organoids.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. The application of liver cancer organoids in tumour precision medicine: A comprehensive review.iLIVER · 2025
   Review
2. Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine.Cells · 2023
   Review
3. Stem cells for organoids.Smart medicine · 2022
   Review
4. Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids.Hepatology international · 2021
   Review
5. Promises and Challenges of Organoid-Guided Precision Medicine.Med (New York, N.Y.) · 2021
   Review
6. Organoids for the Study of Liver Cancer.Seminars in liver disease · 2021
   Review
7. Leveraging 3D Model Systems to Understand Viral Interactions with the Respiratory Mucosa.Viruses · 2020
   Review

Corrections and comments

• Comment on
  Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing.2020

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as